| |
 |
|
Class Information
Number: 514/291
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Polycyclo ring system having the six-membered hetero ring as one of the cyclos > Tricyclo ring system having the six-membered hetero ring as one of the cyclos > Plural hetero atoms in the tricyclo ring system
Description: Subject matter wherein the tricyclo ring system contains at least one ring hetero atom in addition to the ring nitrogen of the six-membered hetero ring.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7622477 |
Isomers and 42-epimers of rapamycin alkyl ether analogs, methods of making and using the same |
Nov. 24, 2009 |
| 7601734 |
Cyclic amine compound |
Oct. 13, 2009 |
| 7598262 |
Method for treating diabetes |
Oct. 6, 2009 |
| 7598263 |
Cyanoquinoline derivatives, their preparation, their use, and medicaments comprising them |
Oct. 6, 2009 |
| 7589100 |
Non-hygroscopic and powdery amorphous pimecrolimus |
Sep. 15, 2009 |
| 7585517 |
Transscleral delivery |
Sep. 8, 2009 |
| 7579358 |
Aerosol formulation for inhalation comprising an anticholinergic |
Aug. 25, 2009 |
| 7572804 |
Macrolides |
Aug. 11, 2009 |
| 7560457 |
Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders |
Jul. 14, 2009 |
| 7553842 |
Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases |
Jun. 30, 2009 |
| 7553843 |
Process for the preparation of purified crystalline CCI-779 |
Jun. 30, 2009 |
| 7550479 |
Modified Pictet-Spengler reaction and products prepared therefrom |
Jun. 23, 2009 |
| 7541365 |
Chemokine receptor antagonists and methods of use therefor |
Jun. 2, 2009 |
| 7538119 |
41-Methoxy isotope labeled rapamycin 42-ester |
May. 26, 2009 |
| 7528145 |
Use of an mTOR inhibitor in treatment of uterine leiomyoma |
May. 5, 2009 |
| 7507745 |
Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins |
Mar. 24, 2009 |
| 7470682 |
Rapamycin analogues and the uses thereof in the treatment of neurological disorders |
Dec. 30, 2008 |
| 7465741 |
C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants |
Dec. 16, 2008 |
| 7465742 |
Heterocyclic compounds having anti-HBV activity |
Dec. 16, 2008 |
| 7462367 |
Anticholinergic powder formulations for inhalation |
Dec. 9, 2008 |
| 7455853 |
Medical devices containing rapamycin analogs |
Nov. 25, 2008 |
| 7446111 |
Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions |
Nov. 4, 2008 |
| 7442707 |
CCI-779 polymorph and use thereof |
Oct. 28, 2008 |
| 7439252 |
Ascomycin crystalline forms and preparation thereof |
Oct. 21, 2008 |
| 7432277 |
Phosphorus-containing macrocycles |
Oct. 7, 2008 |
| 7431916 |
Administration of medicinal dry powders |
Oct. 7, 2008 |
| 7429600 |
Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments |
Sep. 30, 2008 |
| 7419985 |
4-Phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
Sep. 2, 2008 |
| 7419986 |
Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans |
Sep. 2, 2008 |
| 7417051 |
Medicaments comprising betamimetics and a novel anticholinergic |
Aug. 26, 2008 |
| 7405224 |
Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions |
Jul. 29, 2008 |
| RE40418 |
Treatment of neoplasms with CCI-779/EKB-569 combination |
Jul. 1, 2008 |
| 7384953 |
Purification of rapamycin |
Jun. 10, 2008 |
| 7384947 |
Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
Jun. 10, 2008 |
| 7378426 |
Fused heterotricyclic compounds as inhibitors of 17.beta.-hydroxysteroid dehydrogenase 3 |
May. 27, 2008 |
| 7378105 |
Drug delivery systems, kits, and methods for administering zotarolimus and paclitaxel to blood vessel lumens |
May. 27, 2008 |
| 7368457 |
Bridged N-arylsulfonylpiperidines as gamma-secretase inhibitors |
May. 6, 2008 |
| 7357942 |
Compositions, systems, and kits for administering zotarolimus and paclitaxel to blood vessel lumens |
Apr. 15, 2008 |
| 7354949 |
Therapeutic agent for bladder irritative symptoms associated with benign prostatic hyperplasia |
Apr. 8, 2008 |
| 7345053 |
Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use |
Mar. 18, 2008 |
| 7335666 |
Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans |
Feb. 26, 2008 |
| 7332175 |
Long-acting drug combinations for the treatment of respiratory complaints |
Feb. 19, 2008 |
| 7320985 |
Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid |
Jan. 22, 2008 |
| 7311894 |
HFA suspension formulations containing an anticholinergic |
Dec. 25, 2007 |
| 7309707 |
Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament |
Dec. 18, 2007 |
| 7300942 |
Production of polyketides and other natural products |
Nov. 27, 2007 |
| 7297704 |
Cycloalkyfused indole, benzothiophene, benzofuran and idene derivatives |
Nov. 20, 2007 |
| 7297703 |
Macrolides |
Nov. 20, 2007 |
| 7288543 |
Opioid receptor antagonists |
Oct. 30, 2007 |
| 7282505 |
Rapamycin polymorphs and uses thereof |
Oct. 16, 2007 |
|
|
|
